Pathstone Holdings
INSM icon

Pathstone Holdings’s Insmed INSM Stock Holding History

Pathstone Holdings’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.55M Sell
23,914
-3,335
-12% -$404K 0.01% 980
2026
Q1 		$4.46M Buy
27,249
+295
+1% +$45.4K 0.02% 614
2025
Q4 		$4.69M Sell
26,954
-4,667
-15% -$852K 0.02% 591
2025
Q3 		$4.55M Sell
31,621
-7,006
-18% -$858K 0.02% 590
2025
Q2 		$3.89M Sell
38,627
-6,906
-15% -$528K 0.02% 642
2025
Q1 		$3.47M Buy
45,533
+8,388
+23% +$642K 0.02% 699
2024
Q4 		$2.56M Buy
37,145
+1,601
+5% +$115K 0.01% 844
2024
Q3 		$2.59M Buy
35,544
+3,070
+9% +$227K 0.01% 845
2024
Q2 		$2.18M Buy
+32,474
New +$1.26M 0.01% 886

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Pathstone Holdings's INSM Position: Q2 2026 in Review

Pathstone Holdings reduced its Insmed (INSM) stake by 12% in Q2 2026, selling an estimated $404K and leaving 23,914 shares worth $2.55M. The position accounts for 0.01% of the portfolio, ranked #980.

Pathstone Holdings first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.69M in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Pathstone Holdings held 23,914 shares of Insmed worth $2.55M as of Q2 2026.
  • Pathstone Holdings sold 3,335 Insmed shares in Q2 2026, an estimated $404K.
  • Insmed made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #980 holding.
  • Pathstone Holdings first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • Pathstone Holdings's Insmed position peaked at $4.69M in Q4 2025.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.